Oil Prices Surge: What It Means for North American Energy Investors
U.S. crude oil prices exceed $102 per barrel, raising questions for energy investors amid geopolitical tensions.
Oracle's Restructuring Costs: Implications for Investors and Market Dynamics
Oracle's restructuring costs have surged to $2.8 billion, raising concerns about its market competitiveness and earnings outlook.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Activist Investor Backs Seraxis Takeover of Sernova: Implications for the Canadian Biotech Sector
A shareholder's support for Seraxis's takeover of Sernova signals potential shifts in the Canadian biotech landscape.
FDA Delays Exelixis' Zanzalintinib Review: What It Means for Investors
The FDA's delay in reviewing Exelixis' zanzalintinib raises questions for investors about future revenue and growth.
Crude Oil Prices Surge Past $102: Implications for US and Canadian Energy Markets
Crude oil prices have surpassed $102, driven by geopolitical tensions and supply concerns, impacting US and Canadian ene…
Consumer Sentiment Plummets as Inflation Fears Rise, Potential Fed Rate Hike Looms
Consumer sentiment drops to 47.8, sparking inflation concerns and signaling possible Fed interest rate hikes.
Exelixis Faces Setback as FDA Extends Review of Zanzalintinib
Exelixis faces uncertainty as the FDA prolongs its review of zanzalintinib, raising questions about future revenue and s…
SPS Commerce Stock Jumps Amid Acquisition Talks with GTCR
SPS Commerce shares surged as GTCR expresses acquisition interest. Explore the implications for the tech sector.
NextEra and Dominion Merger: A New Era for U.S. Utilities
The merger between NextEra Energy and Dominion Energy could reshape the U.S. utility landscape, impacting customers and …
Merck and Moderna's mRNA Breakthrough: Implications for the Future of Cancer Treatment
The Phase 3 INTerpath-001 trial results present significant implications for Merck and Moderna's cancer treatment strate…
Quantum BioPharma's FDA Clearance: A Game Changer for MS Treatment
Quantum BioPharma's FDA clearance for Lucid-MS could reshape MS treatment and enhance investor confidence.